Hongo, H., Kosaka, T., Suzuki, Y., Mikami, S., Fukada, J., & Oya, M. (2021). Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways. Nature Portfolio.
Style de citation Chicago (17e éd.)Hongo, Hiroshi, Takeo Kosaka, Yoko Suzuki, Shuji Mikami, Junichi Fukada, et Mototsugu Oya. Topoisomerase II Alpha Inhibition Can Overcome Taxane-resistant Prostate Cancer Through DNA Repair Pathways. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Hongo, Hiroshi, et al. Topoisomerase II Alpha Inhibition Can Overcome Taxane-resistant Prostate Cancer Through DNA Repair Pathways. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.